Skip to main content
Press slash or control plus K to focus the search. Use the arrow keys to navigate results and press enter to open a threat.
Reconnecting to live updates…

CVE-2026-5781: CWE-285 Improper Authorization in MphRx Minerva

0
High
VulnerabilityCVE-2026-5781cvecve-2026-5781cwe-285
Published: Tue Apr 28 2026 (04/28/2026, 11:44:26 UTC)
Source: CVE Database V5
Vendor/Project: MphRx
Product: Minerva

Description

An authorization vulnerability in MphRx's Minerva V3.6.0, specifically in the '/minerva/moUser/update' endpoint, could allow an authenticated user with user modification privileges to escalate their privileges by sending an HTTP request with a manipulated 'identifier' field. Successful exploitation of this vulnerability could allow an authenticated user to obtain administrator privileges. It is not possible to escalate privileges through the graphical user interface.

AI-Powered Analysis

Machine-generated threat intelligence

AILast updated: 04/28/2026, 13:21:44 UTC

Technical Analysis

This vulnerability (CVE-2026-5781) in MphRx Minerva 3.6.0 involves improper authorization (CWE-285) in the '/minerva/moUser/update' endpoint. Specifically, an authenticated user who already has user modification privileges can escalate to administrator privileges by sending a crafted HTTP request with a manipulated 'identifier' field. The issue does not allow privilege escalation via the graphical user interface, indicating the flaw is in the backend API authorization checks. The CVSS 4.0 base score is 8.5, reflecting network attack vector, low attack complexity, no user interaction, and high impact on confidentiality, integrity, and availability. The vendor has not provided a patch or official remediation level, and this is not a cloud service, so remediation depends on vendor updates or workarounds.

Potential Impact

Successful exploitation allows an authenticated user with user modification privileges to gain administrator privileges, potentially leading to full system control. This could compromise system confidentiality, integrity, and availability. The vulnerability does not allow privilege escalation through the graphical user interface, limiting exploitation to crafted HTTP requests. There are no known active exploits reported.

Mitigation Recommendations

Patch status is not yet confirmed — check the vendor advisory for current remediation guidance. Until an official fix is released, restrict user modification privileges to trusted users only and monitor for unusual API requests targeting the '/minerva/moUser/update' endpoint. Avoid granting unnecessary privileges to users. Follow vendor communications for updates on patches or official mitigations.

Pro Console: star threats, build custom feeds, automate alerts via Slack, email & webhooks.Upgrade to Pro

Technical Details

Data Version
5.2
Assigner Short Name
INCIBE
Date Reserved
2026-04-08T08:32:51.109Z
Cvss Version
4.0
State
PUBLISHED
Remediation Level
null

Threat ID: 69f0b132cbff5d86100ea256

Added to database: 4/28/2026, 1:08:02 PM

Last enriched: 4/28/2026, 1:21:44 PM

Last updated: 4/29/2026, 6:45:14 AM

Views: 5

Community Reviews

0 reviews

Crowdsource mitigation strategies, share intel context, and vote on the most helpful responses. Sign in to add your voice and help keep defenders ahead.

Sort by
Loading community insights…

Want to contribute mitigation steps or threat intel context? Sign in or create an account to join the community discussion.

Actions

PRO

Updates to AI analysis require Pro Console access. Upgrade inside Console → Billing.

Please log in to the Console to use AI analysis features.

Need more coverage?

Upgrade to Pro Console for AI refresh and higher limits.

For incident response and remediation, OffSeq services can help resolve threats faster.

Latest Threats

Breach by OffSeqOFFSEQFRIENDS — 25% OFF

Check if your credentials are on the dark web

Instant breach scanning across billions of leaked records. Free tier available.

Scan now
OffSeq TrainingCredly Certified

Lead Pen Test Professional

Technical5-day eLearningPECB Accredited
View courses